Krsnaa Diagnostics Q3FY26 Results: Revenue Growth Amid Profit Decline
Krsnaa Diagnostics announced mixed Q3FY26 results with consolidated revenue growing 3.84% to ₹1,812.01 million year-over-year, while net profit declined 21.48% to ₹152.46 million. The healthcare diagnostics company showed stronger nine-month performance with revenue up 9.24% and profit increasing 4.88%, though it continues facing tax assessment challenges with ₹513.86 million in demands under appeal across multiple years.
*this image is generated using AI for illustrative purposes only.
Krsnaa Diagnostics has announced its Q3FY26 financial results for the quarter ended December 31, 2025, showing revenue growth alongside declining profitability. The healthcare diagnostics company reported mixed performance with consolidated net profit of ₹152.46 million compared to ₹194.15 million in the same quarter of the previous year, representing a year-over-year decrease of 21.48%.
Financial Performance Overview
The company's Q3FY26 results demonstrate contrasting trends across key financial metrics. While consolidated revenue showed positive momentum, net profitability faced significant headwinds during the quarter.
| Metric: | Q3FY26 | Q3FY25 | Change (%) |
|---|---|---|---|
| Consolidated Revenue: | ₹1,812.01 million | ₹1,745.12 million | +3.84% |
| Consolidated Net Profit: | ₹152.46 million | ₹194.15 million | -21.48% |
| Standalone Revenue: | ₹1,594.32 million | ₹1,651.57 million | -3.47% |
| Standalone Net Profit: | ₹164.92 million | ₹216.00 million | -23.63% |
Revenue Performance Analysis
Krsnaa Diagnostics achieved consolidated revenue from operations of ₹1,812.01 million in Q3FY26, marking growth from ₹1,745.12 million recorded in the corresponding quarter of the previous year. This revenue expansion of 3.84% reflects the company's continued market presence in the healthcare diagnostics sector.
However, standalone revenue from operations declined to ₹1,594.32 million from ₹1,651.57 million year-over-year, indicating mixed performance across different business segments.
Nine-Month Performance Metrics
For the nine months ended December 31, 2025, the company demonstrated stronger overall performance with consolidated revenue reaching ₹5,801.70 million compared to ₹5,310.84 million in the corresponding period last year, representing growth of 9.24%.
| Parameter: | 9M FY26 | 9M FY25 | Growth (%) |
|---|---|---|---|
| Consolidated Revenue: | ₹5,801.70 million | ₹5,310.84 million | +9.24% |
| Consolidated Net Profit: | ₹597.11 million | ₹569.32 million | +4.88% |
| Standalone Revenue: | ₹5,179.29 million | ₹5,070.42 million | +2.15% |
| Standalone Net Profit: | ₹592.93 million | ₹617.46 million | -3.97% |
Tax Assessment Challenges
The company continues to face ongoing tax assessment proceedings following search operations conducted under sections 132(1) and 133A of the Income Tax Act, 1961. The Income Tax authorities have raised a total demand of ₹513.86 million across multiple assessment years from AY 2017-18 to AY 2023-24.
Krsnaa Diagnostics has filed appeals against these assessment orders and paid ₹102.77 million under protest. The company received additional show cause notices dated January 7, 2026, for AY 2018-19 and AY 2019-20, and has submitted preliminary information in response.
Earnings Per Share Performance
The company's earnings per share metrics reflect the profit decline, with consolidated basic EPS for Q3FY26 at ₹4.72 compared to ₹6.01 in the same quarter last year. For the nine-month period, consolidated basic EPS improved to ₹18.45 from ₹17.63 year-over-year, indicating better cumulative performance despite quarterly challenges.
Historical Stock Returns for Krsnaa Diagnostics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.24% | -4.29% | -7.32% | -21.40% | -8.42% | -34.22% |
15
